Volume 64, Issue 3, Pages (March 2016)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 61, Issue 1, Pages (July 2014)

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Volume 59, Issue 1, Pages (July 2013)

Thoracic empyema in patients with liver cirrhosis: Clinical characteristics and outcome analysis of thoracoscopic management Ke-Cheng Chen, MD, Jou-Wei.

Citrus reticulata peel improves patient tolerance of low-volume polyethylene glycol for colonoscopy preparation Hung-Chieh Lan, Ying Liang, Hsiu-Chuan.

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma Yingjie.

Inflammasomes in liver diseases

Masatoshi Kudo Clinical Gastroenterology and Hepatology

BCLC Outperforms HKLC Staging of Hepatocellular Carcinoma in Multiethnic Asians – Real-World Perspective ESPS Manuscript NO:

MELD: the holy grail of organ allocation?

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.

A New Model to Estimate Survival for Hepatocellular Carcinoma Patients

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis Wichit Srikureja,

Volume 146, Issue 7, Pages e3 (June 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Non-invasive diagnosis of non-alcoholic fatty liver disease

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease Chung-Ping Hsu, MD,

Predictive Factors For Do-Not-Resuscitate Designation Among Terminally Ill Cancer Patients Receiving Care From a Palliative Care Consultation Service

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Pyogenic Liver Abscess as the Initial Manifestation of Underlying Hepatocellular Carcinoma Yi-Tsung Lin, MD, Chia-Jen Liu, MD, Tzeng-Ji Chen, MD, Te-Li.

Living donor liver transplantation: is the hype over?

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer

Reply to: “DCD consensus and futility in liver transplantation”

The place of downstaging for hepatocellular carcinoma

Volume 58, Issue 3, Pages (March 2013)

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers Hidenori Toyoda, Takashi Kumada, Yukio Osaki, Hiroko.

Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas Hung–Hsu Hung, Yi–You Chiou,

Mauro Bernardi, Stefano Gitto, Maurizio Biselli Journal of Hepatology

Volume 146, Issue 7, Pages e3 (June 2014)

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally.

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 44, Issue 1, Pages (January 2006)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 62, Issue 5, Pages (May 2015)

Objective Palliative Prognostic Score Among Patients With Advanced Cancer Yen-Ting Chen, MD, Chih-Te Ho, MD, Hua-Shai Hsu, MD, Po-Tsung Huang, MD, Chin-Yu.

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

EASL Clinical Practice Guidelines: Wilson’s disease

Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry Bing-Yen Wang, MD, Jing-Yang Huang, Ching-Yuan Cheng, MD, Ching-Hsiung Lin, MD,

Volume 127, Issue 6, Pages (December 2004)

Volume 41, Issue 4, Pages (October 2004)

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Molecular prognostication of liver cancer: End of the beginning

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Explore the Radiotherapeutic Clinical Target Volume Delineation for Thoracic Esophageal Squamous Cell Carcinoma from the Pattern of Lymphatic Metastases

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma Yingjie.

Chetana Lim, Chady Salloum, Daniel Azoulay

Volume 64, Issue 6, Pages (June 2016)

Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer Elaine Y.L. Leung, MB ChB,

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns Kuo-Hsuan Hsu, MD, Kun-Chieh Chen, MD,

Volume 66, Issue 3, Pages (March 2017)

Volume 62, Issue 3, Pages (March 2015)

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Carcinoma of the esophagus: Prognostic significance of histologic type

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma Jin-de Chen, Chun-jen Liu, Po-huang Lee, Pei-jer.

Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally.

Presentation transcript:

Volume 64, Issue 3, Pages 601-608 (March 2016) Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Chien-Wei Su, Yi-Hsiang Huang, Fa-Yauh Lee, Han-Chieh Lin, Teh-Ia Huo Journal of Hepatology Volume 64, Issue 3, Pages 601-608 (March 2016) DOI: 10.1016/j.jhep.2015.10.029 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2016 64, 601-608DOI: (10. 1016/j. jhep. 2015. 10 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Distribution of patients in 11 staging systems for hepatocellular carcinoma. Journal of Hepatology 2016 64, 601-608DOI: (10.1016/j.jhep.2015.10.029) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Comparison of survival distributions by (A) BCLC, (B) HKLC, (C) CLIP, (D) TIS, (E) JIS, and (F) Tokyo staging systems. There were significant differences in survival distributions between all adjacent stages except between HKLC stage IV/V, JIS score 4/5, and Tokyo score 5 through 8. BCLC, Barcelona Clínic Liver Cancer; HKLC, Hong Kong Liver Cancer; CLIP, Cancer of the Liver Italian Program; TIS, Taipei Integrated Scoring System; JIS, Japan Integrated Staging. (This figure appears in colour on the web.) Journal of Hepatology 2016 64, 601-608DOI: (10.1016/j.jhep.2015.10.029) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Comparison of survival distributions by (A) AJCC TNM-7, (B) TNM by LCSGJ, (C) Okuda, (D) CUPI, and (E) French staging systems. Significant differences in survival were found between all adjacent stages. AJCC, American Joint Committee on Cancer; TNM, Tumor-Node-Metastasis; LCSGJ, Liver Cancer Study Group of Japan; CUPI, Chinese University Prognostic Index. (This figure appears in colour on the web.) Journal of Hepatology 2016 64, 601-608DOI: (10.1016/j.jhep.2015.10.029) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions